Protara Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Protara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.3M, a 15.2% decline year-over-year.
  • Protara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$45.9M, a 36.3% increase year-over-year.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$43.6M, a 35% increase from 2022.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$67.1M, a 41.2% decline from 2021.
  • Protara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$47.5M, a 37.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$43.6M +$23.4M +35% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$67.1M -$19.6M -41.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$47.5M -$13M -37.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 -$34.4M -$26.6M -340% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$7.83M +$13.5M +63.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$21.4M +$8.99M +29.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$30.4M -$1.66M -5.77% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 -$28.7M -$7.84M -37.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 -$20.9M -$13.3M -175% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$7.58M -$458K -6.43% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$7.12M +$874K +10.9% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$8M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.